Get the Stockscreener App
56.00
3.13%
1.70
After Hours:
56.00
Astrana Health Inc stock is traded at $56.00, with a volume of 190.99K.
It is up +3.13% in the last 24 hours and down -6.50% over the past month.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Its operating segment is the healthcare delivery segment.
See More
Previous Close:
$54.30
Open:
$54.09
24h Volume:
190.99K
Relative Volume:
0.79
Market Cap:
$2.50B
Revenue:
$1.45B
Net Income/Loss:
$62.42M
P/E Ratio:
-
EPS:
-
Net Cash Flow:
$52.44M
1W Performance:
+0.29%
1M Performance:
-6.50%
6M Performance:
+49.49%
1Y Performance:
+0.00%
1-Day Range:
$54.00
$56.19
1-Week Range:
$53.68
$56.34
52-Week Range:
$34.91
$63.20
Astrana Health Inc Stock (ASTH) Company Profile
Name
Astrana Health Inc
Sector
Industry
Phone
(626) 282-0288
Address
1668 S. GARFIELD AVENUE, ALHAMBRA
Astrana Health Inc Stock (ASTH) Latest News
State of Alaska Department of Revenue Buys New Stake in Astrana Health, Inc. (NASDAQ:ASTH) - MarketBeat
Louisiana State Employees Retirement System Makes New Investment in Astrana Health, Inc. (NASDAQ:ASTH) - MarketBeat
F M Investments LLC Takes $11.74 Million Position in Astrana Health, Inc. (NASDAQ:ASTH) - MarketBeat
Institutional investors may overlook Astrana Health, Inc.'s (NASDAQ:ASTH) recent US$93m market cap drop as long-term gains remain positive - Simply Wall St
Do You Believe in the Long-Term Growth Potential of Astrana Health (ASTH)? - Insider Monkey
Analysts Estimate Astrana Health, Inc. (ASTH) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Astrana Health (ASTH) to Release Earnings on Thursday - MarketBeat
SteelPeak Wealth LLC Acquires Shares of 679,984 Astrana Health, Inc. (NASDAQ:ASTH) - MarketBeat
Short Interest in Astrana Health, Inc. (NASDAQ:ASTH) Declines By 16.2% - MarketBeat
Astrana Health, Inc. (NASDAQ:ASTH) Receives Average Rating of "Buy" from Brokerages - MarketBeat
NorthCrest Asset Manangement LLC Purchases New Holdings in Astrana Health, Inc. (NASDAQ:ASTH) - MarketBeat
Guidance Capital Inc. Purchases New Stake in Astrana Health, Inc. (NASDAQ:ASTH) - MarketBeat
Astrana Health, Inc. Schedules 2024 Third Quarter Financial Results Release and Conference Call - WV News
Astrana Health (NASDAQ:ASTH) jumps 9.7% this week, though earnings growth is still tracking behind five-year shareholder returns - Simply Wall St
Astrana Health (NASDAQ:ASTH) Reaches New 12-Month HighHere's What Happened - MarketBeat
Astrana Health (NASDAQ:ASTH) Sees Strong Trading VolumeHere's Why - MarketBeat
Astrana Health gets Buy rating from TD Cowen amid expansion progress - Investing.com Australia
Astrana Health (NASDAQ:ASTH) Now Covered by TD Cowen - MarketBeat
SG Americas Securities LLC Purchases Shares of 11,742 Astrana Health, Inc. (NASDAQ:ASTH) - MarketBeat
KeyBanc starts Astrana Health coverage with Sector Weight rating By Investing.com - Investing.com Canada
Astrana Health (NASDAQ:ASTH) Receives New Coverage from Analysts at KeyCorp - MarketBeat
KeyBanc starts Astrana Health coverage with Sector Weight rating - Investing.com
Astrana Health to buy Collaborative Health Systems - MSN
Centene completes sale of management services subsidiary - Healthcare Dive
Astrana Health acquires CHS to expand care delivery capabilities - Yahoo! Voices
Astrana Health completes acquisition of healthcare networks By Investing.com - Investing.com Australia
Astrana Health completes acquisition of healthcare networks - Investing.com
Healthy Upside Potential: Astrana Health Inc. (ASTH) - SETE News
Astrana Health Completes Acquisition of Collaborative Health Systems - cnhinews.com
Astrana Health, Inc.'s (NASDAQ:ASTH) P/E Is Still On The Mark Following 25% Share Price Bounce - Simply Wall St
Astrana Health shares poised for growth with updated price target amid competitive landscape By Investing.com - Investing.com South Africa
Astrana Health shares poised for growth with updated price target amid competitive landscape - Investing.com
Astrana Health (NASDAQ:ASTH) Sets New 52-Week High Following Analyst Upgrade - Defense World
Astrana Health, Inc. (NASDAQ:ASTH) Given Average Recommendation of "Buy" by Analysts - MarketBeat
BTIG Research Increases Astrana Health (NASDAQ:ASTH) Price Target to $70.00 - MarketBeat
What 5 Analyst Ratings Have To Say About Astrana Health - Benzinga
500: Something went wrong - Investing.com UK
SCAN, Astrana Launch MA Plan Tailored to Asian Older Adults - MedCity News
Be Wary Of Astrana Health (NASDAQ:ASTH) And Its Returns On Capital - Yahoo Finance
Ascential Shareholding Shifts with Societe Generale’s Move - TipRanks
Magnetar Financial LLC Buys Shares of 20,305 Astera Labs, Inc. (NASDAQ:ALAB) - Defense World
Views of Wall Street’s Leading Experts on Astera Labs Inc. - SETE News
Prospects for datopotamab deruxtecan dented by update - The Pharma Letter
AstraZeneca shares rally 13%, hit record high as firm gets nod for cancer drug Durvalumab - CNBCTV18
Astera Labs, Inc. (NASDAQ:ALAB) Shares Sold by American Century Companies Inc. - Defense World
AstraZeneca Pharma gets nod to sell immunotherapy drug Durvalumab; stock surges - Fortune India
AstraZeneca Pharma shares rally 13%, hit 52-week high after receiving nod for cancer drug Durvalumab - The Economic Times
AstraZeneca Pharma Shares Surge 12% After Approval to Launch Cancer Drug in India - EquityPandit
Pharma stock jumps 12% after it receives nod to import drugs for cancer and tumors - Trade Brains
AstraZeneca Pharma receives nod for cancer drug Durvalumab; stock soars 12% - Business Standard
AstraZeneca stock surges over 8% – Check out the reason behind it - Business Upturn
Astrana Health Inc Stock (ASTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Astrana Health Inc Stock (ASTH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Lam Thomas S. | Director |
Sep 09 '24 |
Option Exercise |
18.65 |
28,046 |
523,058 |
409,901 |
| Kitayama Mitchell W | Director |
Sep 10 '24 |
Option Exercise |
15.35 |
11,000 |
168,850 |
21,314 |
| Chiang John | Director |
Sep 09 '24 |
Option Exercise |
15.35 |
11,000 |
168,850 |
19,414 |
| Schmidt David | Director |
Aug 14 '24 |
Option Exercise |
16.07 |
14,409 |
231,610 |
23,723 |
| Schmidt David | Director |
Dec 06 '23 |
Option Exercise |
18.11 |
7,500 |
135,825 |
7,500 |
| Kitayama Mitchell W | Director |
Dec 06 '23 |
Option Exercise |
18.11 |
7,500 |
135,825 |
7,500 |
1.92%
4.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):